Comparison of Clinical Efficacy Between Arterial Infusion and Embolization with Arterial Infusion and Argon Plasma Coagulation in the Treatment of Patients with Advanced Central Type Lung Cancer

WANG Mei-fang,LIU Yu-quan,TANG Yi-jun,XIONG Chang,LU Jin-chang,LIU Xian-jun,LIU Wei-shun,LEI Huai-ding,LUO Guo-shi

DOI: https://doi.org/10.3969/j.issn.1009-6663.2013.03.015

2013-01-01

Abstract:Objective To study the therapeutic effects to combine bronchial arterial chemotherapy with argon plasma coagulation on patients with advanced central type lung cancer.Methods 45 cases with central type lung cancer were collected,including one group treated by bronchial arterial chemotherapy combined with embolization and another group treated by bronchial arterial chemotherapy combined with argon plasma coagulation(APC).Results The solid tumor response rate and airway narrowing recanalization rate of improvement in the group treated by bronchial arterial chemotherapy combined with argon plasma coagulation were respectively 87.5% and 91.7%,which were significantly higher than the group treated by bronchial arterial chemotherapy combined with embolization,respectively 57.1% and 52.4%.At the same time,the patients treated by bronchial arterial chemotherapy combined with argon plasma coagulation enjoyed better quality of life recently.Conclusion The clinical therapeutic effects of bronchial arterial chemotherapy combined with argon plasma coagulation on patients with advanced stage central type lung cancer is apparently superior comparing with that of bronchial arterial chemotherapy and embolization treatment group.The combined therapy of arterial infusion and APC can improve patients' life quality,thus it is worth being promoted clinically.